LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1

Ping Luo; Shugui Wu; Kaibao Ji; Xia Yuan; Hongmi Li; Jinping Chen; Yunfei Tian; Yang Qiu; Xiaoming Zhong

doi:10.1371/journal.pone.0223035

Loading metrics

Open Access

Peer-reviewed

Research Article

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1

Ping Luo ,

Contributed equally to this work with: Ping Luo, Shugui Wu, Kaibao Ji

Roles Data curation, Formal analysis, Software

Affiliation Department of Breast Tumor of Nanchang Third Hospital, Nanchang, Jiangxi, China
⨯
Shugui Wu ,

Contributed equally to this work with: Ping Luo, Shugui Wu, Kaibao Ji

Roles Data curation, Formal analysis, Investigation, Methodology, Resources, Visualization

Affiliation Department of Oncology of Ganzhou People’s Hospital, Ganzhou, Jiangxi, China
⨯
Kaibao Ji ,

Contributed equally to this work with: Ping Luo, Shugui Wu, Kaibao Ji

Roles Conceptualization, Data curation, Formal analysis

Affiliation Department of Ophthalmology, Renmin Hospital of Wuhan University, Hubei, China

https://orcid.org/0000-0002-7704-8438

⨯
Xia Yuan,

Roles Writing – original draft

Affiliation Department of Tumor Radiotherapy of Jiangxi Province Cancer Hospital, Nanchang, Jiangxi, China
⨯
Hongmi Li,

Roles Writing – original draft

Affiliation Department of Tumor Radiotherapy of Jiangxi Province Cancer Hospital, Nanchang, Jiangxi, China
⨯
Jinping Chen,

Roles Software, Visualization

Affiliation Department of Oncology of Yichun People’s Hospital, Yichun, Jiangxi, China
⨯
Yunfei Tian,

Roles Resources, Validation, Visualization

Affiliation Department of Interventional of Ganzhou People’s Hospital, Ganzhou, Jiangxi, China
⨯
Yang Qiu ,

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition

* E-mail: QY416523616629@163.com (YQ); jddxf2012@126.com (XZ)

Affiliation Department of Tumor Radiotherapy of Jiangxi Province Cancer Hospital, Nanchang, Jiangxi, China
⨯
Xiaoming Zhong

Roles Funding acquisition, Writing – review & editing

* E-mail: QY416523616629@163.com (YQ); jddxf2012@126.com (XZ)

Affiliation Department of Tumor Radiotherapy of Jiangxi Province Cancer Hospital, Nanchang, Jiangxi, China

https://orcid.org/0000-0002-3535-6678

⨯

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1

Ping Luo,
Shugui Wu,
Kaibao Ji,
Xia Yuan,
Hongmi Li,
Jinping Chen,
Yunfei Tian,
Yang Qiu,
Xiaoming Zhong

Published: November 24, 2020
https://doi.org/10.1371/journal.pone.0223035

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Long non-coding RNA
Is the Subject Area "Long non-coding RNA" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cell viability testing
Is the Subject Area "Cell viability testing" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.